We examined the clinical significance of their upregulation and the association with PTOV1, highly overexpressed in aggressive prostate tumors (Supplementary Figure 11) as previously reported [10, 11], using publicly available database containing expression data, clinical and pathological information from prostate tumors of not-treated patients. This evidence concerns the gene PTOV1 and prostate neoplasm.